Bright

▤ Summary

Bright Path’s technology will allow other pharmaceutical companies, research universities, and hospitals to make medicine for those where others can’t or won’t–cost-effectively, safely, securely, and much more quickly than relying on a distributed supply chain. But, their leadership team faced a difficult realization: the organization wasn’t foundationally ready to fully execute their vision. Bright Path Laboratories had established the stable and scalable organization that is ready to execute against the strategy and plan they’d created in 2020. So, getting Bright Path ready to implement its plan simply required a quick refresh to the organization’s OKRs to align with what had been achieved or prioritized and they’re picking up where they left off less than a year ago. After an entire year of organizational growth and shifts, Bright Path’s core strategy didn’t need to change when it came time to implement.

▦ Linked Companies

OnStrategyHQ

$5M to $10M